Skip to main content
Erschienen in: Obesity Surgery 9/2023

22.07.2023 | Original Contributions

Sex-Specific Changes in Body Composition Following Metabolic and Bariatric Surgery Are Associated with the Remission of Metabolic Syndrome

verfasst von: Xianhao Yi, Weizheng Li, Guohui Wang, Pengzhou Li, Xulong Sun, Haibo Tang, Beibei Cui, Jiapu Ling, Ping Luo, Zhibing Fu, Hui Zhou, Liyong Zhu, Shaihong Zhu

Erschienen in: Obesity Surgery | Ausgabe 9/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Metabolic and bariatric surgery (MBS) is the most effective treatment for metabolic syndrome (MetS). However, the mechanism of MetS remission after MBS remains unclear. We aimed to explore the relationship between sex differences, body composition, and the remission of MetS after MBS.

Materials and Methods

Cross-sectional study of 80 patients with obesity and MetS who underwent MBS with case-control design. The International Diabetes Federation criteria were used to define MetS. Body composition was measured using dual-energy X-ray absorptiometry before and 1 year after the operation. In addition to calculating changes in MetS and its prevalence, we performed a multiple logistic regression to determine predictors of MetS remission.

Results

There were significant differences in body composition between males and females after MBS. Both males and females had significant improvements in the overall prevalence of MetS, decreasing from 100 to 21.74% (P <0.001) and from 100 to 35.29% (P <0.001), respectively. A higher percentage of visceral adipose tissue (VAT) reduction tends to be associated with a higher chance of MetS remission in men. In females, the MetS nonremission subgroup had a higher %Trunk lean body mass (LBM), and %Android LBM reduction than the remission subgroup, but the multiple logistic regression analysis result was not statistically significant.

Conclusion

After MBS, reduced VAT might be related to MetS reversibility in males, while reduced LBM may result in MetS nonremission in females.

Graphical Abstract

Literatur
1.
Zurück zum Zitat NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet. 2016(387):1377–96. NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet. 2016(387):1377–96.
2.
Zurück zum Zitat Mitchell JD. Personalizing risk assessment in diabetes mellitus and metabolic syndrome. J Am Coll Cardiol Img. 2021;14:230–2.CrossRef Mitchell JD. Personalizing risk assessment in diabetes mellitus and metabolic syndrome. J Am Coll Cardiol Img. 2021;14:230–2.CrossRef
3.
Zurück zum Zitat Hanipah ZN, Schauer PR. Bariatric surgery as a long-term treatment for type 2 diabetes/metabolic syndrome. Annu Rev Med. 2020;71:1–15.PubMedCrossRef Hanipah ZN, Schauer PR. Bariatric surgery as a long-term treatment for type 2 diabetes/metabolic syndrome. Annu Rev Med. 2020;71:1–15.PubMedCrossRef
5.
Zurück zum Zitat Madsbad S, Dirksen C, Holst JJ. Mechanisms of changes in glucose metabolism and bodyweight after bariatric surgery. Lancet Diabetes Endocrinol. 2014;2:152–64.PubMedCrossRef Madsbad S, Dirksen C, Holst JJ. Mechanisms of changes in glucose metabolism and bodyweight after bariatric surgery. Lancet Diabetes Endocrinol. 2014;2:152–64.PubMedCrossRef
6.
7.
Zurück zum Zitat Alomar AO, Shaheen MF, Almaneea AS, et al. The effect of bariatric surgery on metabolic syndrome: a three-center experience in Saudi Arabia. Obes Surg. 2021;31:3630–6.PubMedCrossRef Alomar AO, Shaheen MF, Almaneea AS, et al. The effect of bariatric surgery on metabolic syndrome: a three-center experience in Saudi Arabia. Obes Surg. 2021;31:3630–6.PubMedCrossRef
8.
Zurück zum Zitat Yu H, Zhang L, Bao Y, et al. Metabolic syndrome after Roux-en-Y gastric bypass surgery in Chinese obese patients with type 2 diabetes. Obes Surg. 2016;26:2190–7.PubMedCrossRef Yu H, Zhang L, Bao Y, et al. Metabolic syndrome after Roux-en-Y gastric bypass surgery in Chinese obese patients with type 2 diabetes. Obes Surg. 2016;26:2190–7.PubMedCrossRef
9.
Zurück zum Zitat Silva LB, Oliveira B, Correia F. Evolution of body composition of obese patients undergoing bariatric surgery. Clinical Nutrition ESPEN. 2019;31:95–9.PubMedCrossRef Silva LB, Oliveira B, Correia F. Evolution of body composition of obese patients undergoing bariatric surgery. Clinical Nutrition ESPEN. 2019;31:95–9.PubMedCrossRef
10.
Zurück zum Zitat Tchernof A, Després JP. Pathophysiology of human visceral obesity: an update. Physiol Rev. 2013;93:359–404.PubMedCrossRef Tchernof A, Després JP. Pathophysiology of human visceral obesity: an update. Physiol Rev. 2013;93:359–404.PubMedCrossRef
11.
Zurück zum Zitat Ibrahim MM. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev. 2010;11:11–8.PubMedCrossRef Ibrahim MM. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev. 2010;11:11–8.PubMedCrossRef
12.
Zurück zum Zitat Després JP, Allard C, Tremblay A, et al. Evidence for a regional component of body fatness in the association with serum lipids in men and women. Metabolism. 1985;34:967–73.PubMedCrossRef Després JP, Allard C, Tremblay A, et al. Evidence for a regional component of body fatness in the association with serum lipids in men and women. Metabolism. 1985;34:967–73.PubMedCrossRef
13.
Zurück zum Zitat Sharma AM, Engeli S, Pischon T. New developments in mechanisms of obesity-induced hypertension: role of adipose tissue. Curr Hypertens Rep. 2001;3:152–6.PubMedCrossRef Sharma AM, Engeli S, Pischon T. New developments in mechanisms of obesity-induced hypertension: role of adipose tissue. Curr Hypertens Rep. 2001;3:152–6.PubMedCrossRef
15.
Zurück zum Zitat Qian J, Scheer F. Sex-dependent link between circadian misalignment and adiposity. Nat Rev Endocrinol. 2020;16:13–5.PubMedCrossRef Qian J, Scheer F. Sex-dependent link between circadian misalignment and adiposity. Nat Rev Endocrinol. 2020;16:13–5.PubMedCrossRef
16.
Zurück zum Zitat Reue K. Sex differences in obesity: X chromosome dosage as a risk factor for increased food intake, adiposity and co-morbidities. Physiol Behav. 2017;176:174–82.PubMedPubMedCentralCrossRef Reue K. Sex differences in obesity: X chromosome dosage as a risk factor for increased food intake, adiposity and co-morbidities. Physiol Behav. 2017;176:174–82.PubMedPubMedCentralCrossRef
17.
Zurück zum Zitat Powell-Wiley TM, Poirier P, Burke LE, et al. Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2021;143:CIR0000000000000973.CrossRef Powell-Wiley TM, Poirier P, Burke LE, et al. Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2021;143:CIR0000000000000973.CrossRef
18.
Zurück zum Zitat CZ JL, Wang Y, et al. Guidelines for surgical treatment of obesity and type 2 diabetes mellitus in China. Chin J Pract Surg. 2014;34:6. CZ JL, Wang Y, et al. Guidelines for surgical treatment of obesity and type 2 diabetes mellitus in China. Chin J Pract Surg. 2014;34:6.
19.
Zurück zum Zitat Agha R, Abdall-Razak A, Crossley E, et al. STROCSS 2019 Guideline: strengthening the reporting of cohort studies in surgery. Int J Surg. 2019;72:156–65.PubMedCrossRef Agha R, Abdall-Razak A, Crossley E, et al. STROCSS 2019 Guideline: strengthening the reporting of cohort studies in surgery. Int J Surg. 2019;72:156–65.PubMedCrossRef
20.
Zurück zum Zitat Brethauer SA, Kim J, El Chaar M, et al. Standardized outcomes reporting in metabolic and bariatric surgery. Obes Surg. 2015;25:587–606.PubMedCrossRef Brethauer SA, Kim J, El Chaar M, et al. Standardized outcomes reporting in metabolic and bariatric surgery. Obes Surg. 2015;25:587–606.PubMedCrossRef
21.
Zurück zum Zitat Alberti G, Zimmet P, Shaw J, et al. The IDF consensus worldwide definition of the metabolic syndrome. The Lancet. 2005;366:1059–62.CrossRef Alberti G, Zimmet P, Shaw J, et al. The IDF consensus worldwide definition of the metabolic syndrome. The Lancet. 2005;366:1059–62.CrossRef
22.
Zurück zum Zitat Wilding J. Weight loss is the major player in bariatric surgery benefits. Nat Med. 2020;26:1678–9.PubMedCrossRef Wilding J. Weight loss is the major player in bariatric surgery benefits. Nat Med. 2020;26:1678–9.PubMedCrossRef
23.
Zurück zum Zitat To VT, Hüttl TP, Lang R, et al. Changes in body weight, glucose homeostasis, lipid profiles, and metabolic syndrome after restrictive bariatric surgery. Exp Clin Endocrinol Diabetes. 2012;120:547–52.PubMedCrossRef To VT, Hüttl TP, Lang R, et al. Changes in body weight, glucose homeostasis, lipid profiles, and metabolic syndrome after restrictive bariatric surgery. Exp Clin Endocrinol Diabetes. 2012;120:547–52.PubMedCrossRef
24.
Zurück zum Zitat Busetto L, Pisent C, Rinaldi D, et al. Variation in lipid levels in morbidly obese patients operated with the LAP-BAND adjustable gastric banding system: effects of different levels of weight loss. Obes Surg. 2000;10:569–77.PubMedCrossRef Busetto L, Pisent C, Rinaldi D, et al. Variation in lipid levels in morbidly obese patients operated with the LAP-BAND adjustable gastric banding system: effects of different levels of weight loss. Obes Surg. 2000;10:569–77.PubMedCrossRef
25.
Zurück zum Zitat Guerreiro V, Neves JS, Salazar D, et al. Long-term weight loss and metabolic syndrome remission after bariatric surgery: the effect of sex, age, metabolic parameters and surgical technique - a 4-year follow-up study. Obes Facts. 2019;12:639–52.PubMedPubMedCentralCrossRef Guerreiro V, Neves JS, Salazar D, et al. Long-term weight loss and metabolic syndrome remission after bariatric surgery: the effect of sex, age, metabolic parameters and surgical technique - a 4-year follow-up study. Obes Facts. 2019;12:639–52.PubMedPubMedCentralCrossRef
26.
Zurück zum Zitat Gloy VL, Briel M, Bhatt DL, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. Bmj. 2013;347:f5934.PubMedPubMedCentralCrossRef Gloy VL, Briel M, Bhatt DL, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. Bmj. 2013;347:f5934.PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat Maïmoun L, Lefebvre P, Aouinti S, et al. Acute and longer-term body composition changes after bariatric surgery. Surg Obes Relat Dis. 2019;15:1965–73.PubMedCrossRef Maïmoun L, Lefebvre P, Aouinti S, et al. Acute and longer-term body composition changes after bariatric surgery. Surg Obes Relat Dis. 2019;15:1965–73.PubMedCrossRef
28.
Zurück zum Zitat Haghighat N, Kazemi A, Asbaghi O, et al. Long-term effect of bariatric surgery on body composition in patients with morbid obesity: a systematic review and meta-analysis. Clin Nutr. 2021;40:1755–66.PubMedCrossRef Haghighat N, Kazemi A, Asbaghi O, et al. Long-term effect of bariatric surgery on body composition in patients with morbid obesity: a systematic review and meta-analysis. Clin Nutr. 2021;40:1755–66.PubMedCrossRef
29.
Zurück zum Zitat Davidson LE, Yu W, Goodpaster B, et al. Fat weight increases while fat-free mass decreases in women 5 years after gastric bypass surgery. Obes Rev. 2016;17:60. Davidson LE, Yu W, Goodpaster B, et al. Fat weight increases while fat-free mass decreases in women 5 years after gastric bypass surgery. Obes Rev. 2016;17:60.
30.
Zurück zum Zitat Domínguez Alvarado GA, Otero Rosales MC, Cala Duran JC, et al. The effect of bariatric surgery on metabolic syndrome: a retrospective cohort study in Colombia. Health science reports. 2023;6:e1090.PubMedPubMedCentralCrossRef Domínguez Alvarado GA, Otero Rosales MC, Cala Duran JC, et al. The effect of bariatric surgery on metabolic syndrome: a retrospective cohort study in Colombia. Health science reports. 2023;6:e1090.PubMedPubMedCentralCrossRef
31.
Zurück zum Zitat Menguer RK, Weston AC, Schmid H. Evaluation of metabolic syndrome in morbidly obese patients submitted to laparoscopic bariatric surgery: comparison of the results between Roux-en-Y gastric bypass and sleeve gastrectomy. Obes Surg. 2017;27:1719–23.PubMedCrossRef Menguer RK, Weston AC, Schmid H. Evaluation of metabolic syndrome in morbidly obese patients submitted to laparoscopic bariatric surgery: comparison of the results between Roux-en-Y gastric bypass and sleeve gastrectomy. Obes Surg. 2017;27:1719–23.PubMedCrossRef
32.
Zurück zum Zitat Mahawar KK, Graham Y, Carr WR, et al. Revisional Roux-en-Y gastric bypass and sleeve gastrectomy: a systematic review of comparative outcomes with respective primary procedures. Obes Surg. 2015;25:1271–80.PubMedCrossRef Mahawar KK, Graham Y, Carr WR, et al. Revisional Roux-en-Y gastric bypass and sleeve gastrectomy: a systematic review of comparative outcomes with respective primary procedures. Obes Surg. 2015;25:1271–80.PubMedCrossRef
33.
Zurück zum Zitat Coblijn UK, Verveld CJ, van Wagensveld BA, et al. Laparoscopic Roux-en-Y gastric bypass or laparoscopic sleeve gastrectomy as revisional procedure after adjustable gastric band--a systematic review. Obes Surg. 2013;23:1899–914.PubMedCrossRef Coblijn UK, Verveld CJ, van Wagensveld BA, et al. Laparoscopic Roux-en-Y gastric bypass or laparoscopic sleeve gastrectomy as revisional procedure after adjustable gastric band--a systematic review. Obes Surg. 2013;23:1899–914.PubMedCrossRef
34.
Zurück zum Zitat Knopp KB, Stakleff KS, Thomas TM, et al. Gender influence on weight and body composition following sleeve gastrectomy: outcomes suggest potential bariatric surgery body composition goals. Bariatric Surgical Practice and Patient Care. 2020;15:205–10. Knopp KB, Stakleff KS, Thomas TM, et al. Gender influence on weight and body composition following sleeve gastrectomy: outcomes suggest potential bariatric surgery body composition goals. Bariatric Surgical Practice and Patient Care. 2020;15:205–10.
35.
Zurück zum Zitat Blouin K, Boivin A, Tchernof A. Androgens and body fat distribution. J Steroid Biochem Mol Biol. 2008;108:272–80.PubMedCrossRef Blouin K, Boivin A, Tchernof A. Androgens and body fat distribution. J Steroid Biochem Mol Biol. 2008;108:272–80.PubMedCrossRef
36.
Zurück zum Zitat Blouin K, Després JP, Couillard C, et al. Contribution of age and declining androgen levels to features of the metabolic syndrome in men. Metabolism. 2005;54:1034–40.PubMedCrossRef Blouin K, Després JP, Couillard C, et al. Contribution of age and declining androgen levels to features of the metabolic syndrome in men. Metabolism. 2005;54:1034–40.PubMedCrossRef
37.
Zurück zum Zitat Gapstur SM, Gann PH, Kopp P, et al. Serum androgen concentrations in young men: a longitudinal analysis of associations with age, obesity, and race. The CARDIA male hormone study. Cancer Epidemiol Biomarkers Prev. 2002;11:1041–7.PubMed Gapstur SM, Gann PH, Kopp P, et al. Serum androgen concentrations in young men: a longitudinal analysis of associations with age, obesity, and race. The CARDIA male hormone study. Cancer Epidemiol Biomarkers Prev. 2002;11:1041–7.PubMed
38.
Zurück zum Zitat Laaksonen DE, Niskanen L, Punnonen K, et al. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care. 2004;27:1036–41.PubMedCrossRef Laaksonen DE, Niskanen L, Punnonen K, et al. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care. 2004;27:1036–41.PubMedCrossRef
39.
Zurück zum Zitat Pasquali R, Casimirri F, Cantobelli S, et al. Effect of obesity and body fat distribution on sex hormones and insulin in men. Metabolism. 1991;40:101–4.PubMedCrossRef Pasquali R, Casimirri F, Cantobelli S, et al. Effect of obesity and body fat distribution on sex hormones and insulin in men. Metabolism. 1991;40:101–4.PubMedCrossRef
40.
Zurück zum Zitat Liu J, Fox CS, Hickson DA, et al. Impact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: the Jackson Heart Study. J Clin Endocrinol Metab. 2010;95:5419–26.PubMedPubMedCentralCrossRef Liu J, Fox CS, Hickson DA, et al. Impact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: the Jackson Heart Study. J Clin Endocrinol Metab. 2010;95:5419–26.PubMedPubMedCentralCrossRef
41.
Zurück zum Zitat Neeland IJ, Yokoo T, Leinhard OD, et al. 21st century advances in multimodality imaging of obesity for care of the cardiovascular patient. J Am Coll Cardiol Img. 2021;14:482–94.CrossRef Neeland IJ, Yokoo T, Leinhard OD, et al. 21st century advances in multimodality imaging of obesity for care of the cardiovascular patient. J Am Coll Cardiol Img. 2021;14:482–94.CrossRef
42.
Zurück zum Zitat Xia L, Hua J, Dray X, et al. Endoscopic visceral fat removal as therapy for obesity and metabolic syndrome: a sham-controlled pilot study (with video). Gastrointest Endosc. 2011;74:637–44.PubMedCrossRef Xia L, Hua J, Dray X, et al. Endoscopic visceral fat removal as therapy for obesity and metabolic syndrome: a sham-controlled pilot study (with video). Gastrointest Endosc. 2011;74:637–44.PubMedCrossRef
43.
Zurück zum Zitat Vaurs C, Diméglio C, Charras L, et al. Determinants of changes in muscle mass after bariatric surgery. Diabetes Metab. 2015;41:416–21.PubMedCrossRef Vaurs C, Diméglio C, Charras L, et al. Determinants of changes in muscle mass after bariatric surgery. Diabetes Metab. 2015;41:416–21.PubMedCrossRef
44.
Zurück zum Zitat Kaneko S, Iida RH, Suga T, et al. Changes in triacylglycerol-accumulated fiber type, fiber type composition, and biogenesis in the mitochondria of the soleus muscle in obese rats. Anat Rec. 2011;294:1904–12.CrossRef Kaneko S, Iida RH, Suga T, et al. Changes in triacylglycerol-accumulated fiber type, fiber type composition, and biogenesis in the mitochondria of the soleus muscle in obese rats. Anat Rec. 2011;294:1904–12.CrossRef
45.
Zurück zum Zitat Nuijten MAH, Eijsvogels TMH, Monpellier VM, et al. The magnitude and progress of lean body mass, fat-free mass, and skeletal muscle mass loss following bariatric surgery: a systematic review and meta-analysis. Obesity reviews. 2021;23:e13370. Nuijten MAH, Eijsvogels TMH, Monpellier VM, et al. The magnitude and progress of lean body mass, fat-free mass, and skeletal muscle mass loss following bariatric surgery: a systematic review and meta-analysis. Obesity reviews. 2021;23:e13370.
46.
Zurück zum Zitat Park SH, Park JH, Park HY, et al. Additional role of sarcopenia to waist circumference in predicting the odds of metabolic syndrome. Clin Nutr. 2014;33:668–72.PubMedCrossRef Park SH, Park JH, Park HY, et al. Additional role of sarcopenia to waist circumference in predicting the odds of metabolic syndrome. Clin Nutr. 2014;33:668–72.PubMedCrossRef
Metadaten
Titel
Sex-Specific Changes in Body Composition Following Metabolic and Bariatric Surgery Are Associated with the Remission of Metabolic Syndrome
verfasst von
Xianhao Yi
Weizheng Li
Guohui Wang
Pengzhou Li
Xulong Sun
Haibo Tang
Beibei Cui
Jiapu Ling
Ping Luo
Zhibing Fu
Hui Zhou
Liyong Zhu
Shaihong Zhu
Publikationsdatum
22.07.2023
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 9/2023
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-023-06741-w

Weitere Artikel der Ausgabe 9/2023

Obesity Surgery 9/2023 Zur Ausgabe

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.